Clinical Trial Update: Phase 1 Study of SON-1010 in Adult Patients With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 trial update for SON-1010 in adults with advanced solid tumors, including soft tissue sarcoma; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Soft Tissue Sarcoma

Drugs mentioned

• SON-1010

Snippet

Sponsor: Sonnet BioTherapeutics | Conditions: Advanced Solid Tumor, Soft Tissue Sarcoma Adult | Phase 1 | Status: ACTIVE_NOT_RECRUITING